These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8053061)

  • 1. A human minor histocompatibility antigen which appears to segregate with the major histocompatibility complex.
    Vinci G; Masset M; Semana G; Vernant JP
    Transplantation; 1994 Aug; 58(3):361-7. PubMed ID: 8053061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple minor histocompatibility antigen-specific cytotoxic T lymphocyte clones can be generated during graft rejection after HLA-identical bone marrow transplantation.
    Marijt WA; Kernan NA; Diaz-Barrientos T; Veenhof WF; O'Reilly RJ; Willemze R; Falkenburg JH
    Bone Marrow Transplant; 1995 Jul; 16(1):125-32. PubMed ID: 7581111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel minor histocompatibility antigen recognized by HLA-A31 restricted cytotoxic T lymphocytes generated from HLA-identical bone marrow donor lymphocytes.
    Yazaki M; Takahashi T; Andho M; Akatsuka Y; Ito T; Miyake Y; Ito Y; Nakamura S; Wada Y
    Bone Marrow Transplant; 1999 Jul; 24(2):129-37. PubMed ID: 10455340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mismatches for two major and one minor histocompatibility antigen correlate with a patient's rejection of a bone marrow graft from a serologically HLA-identical sibling.
    Lienert-Weidenbach K; Valiante NM; Brown C; White C; Johnston-Dow L; McGinnis M; Krausa P; Lakes DM; Wolf JL; Blume KG; Parham P
    Biol Blood Marrow Transplant; 1997 Nov; 3(5):255-60. PubMed ID: 9450920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
    Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB
    Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A human autoreactive T cell line specific for minor histocompatibility antigen(s) isolated from a bone marrow-grafted patient.
    Tilkin AF; Bagot M; Kayibanda M; Vernant JP; Levy JP
    J Immunol; 1986 Dec; 137(12):3772-6. PubMed ID: 3537123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minor histocompatibility antigen-specific, leukemia-reactive cytotoxic T cell clones can be generated in vitro without in vivo priming using chronic myeloid leukemia cells as stimulators in the presence of alpha-interferon.
    Faber LM; van Luxemburg-Heijs SA; Rijnbeek M; Willemze R; Falkenburg JH
    Biol Blood Marrow Transplant; 1996 Feb; 2(1):31-6. PubMed ID: 9078352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The putative role of HLA-C recognition in graft versus host disease (GVHD) and graft rejection after unrelated bone marrow transplantation (BMT).
    Bishara A; Amar A; Brautbar C; Condiotti R; Lazarovitz V; Nagler A
    Exp Hematol; 1995 Dec; 23(14):1667-75. PubMed ID: 8542963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization to chromosome 22 of a gene encoding a human minor histocompatibility antigen.
    Gubarev MI; Jenkin JC; Leppert MF; Buchanan GS; Otterud BE; Guilbert DA; Beatty PG
    J Immunol; 1996 Dec; 157(12):5448-54. PubMed ID: 8955193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'Resistance' to unrelated, DLA-nonidentical canine marrow grafts is unrestricted by the major histocompatibility complex.
    Raff RF; Sandmaier BM; Graham T; Loughran TP; Pettinger M; Storb R
    Exp Hematol; 1994 Aug; 22(9):893-7. PubMed ID: 8062888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recognition of a B cell leukemia-associated minor histocompatibility antigen by CTL.
    Dolstra H; Fredrix H; Preijers F; Goulmy E; Figdor CG; de Witte TM; van de Wiel-van Kemenade E
    J Immunol; 1997 Jan; 158(2):560-5. PubMed ID: 8992968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical consequences of sensitisation to minor histocompatibility antigens before allogeneic bone marrow transplantation.
    Rufer N; Starobinski M; Chapuis B; Gratwohl A; Jeannet M; Helg C; Roosnek E
    Bone Marrow Transplant; 1998 Nov; 22(9):895-8. PubMed ID: 9827818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Family segregation analysis of inheritance of human minor histocompatibility antigen.
    Nishimura M; Mitsunaga S; Uchikawa C; Takahashi K; Tokunaga K; Tadokoro K; Juji T
    Cell Immunol; 1995 Jul; 163(2):319-22. PubMed ID: 7606803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease.
    Mutis T; Gillespie G; Schrama E; Falkenburg JH; Moss P; Goulmy E
    Nat Med; 1999 Jul; 5(7):839-42. PubMed ID: 10395333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A CD8 DE loop peptide analog prevents graft-versus-host disease in a multiple minor histocompatibility antigen-mismatched bone marrow transplantation model.
    Choksi S; Kim JC; Whitaker-Menezes D; Murphy GF; Friedman TM; Korngold R
    Biol Blood Marrow Transplant; 2004 Oct; 10(10):669-80. PubMed ID: 15389433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bi-directional allelic recognition of the human minor histocompatibility antigen HB-1 by cytotoxic T lymphocytes.
    Dolstra H; de Rijke B; Fredrix H; Balas A; Maas F; Scherpen F; Aviles MJ; Vicario JL; Beekman NJ; Ossendorp F; de Witte TM; van de Wiel-van Kemenade E
    Eur J Immunol; 2002 Oct; 32(10):2748-58. PubMed ID: 12355426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
    Russell CA
    Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allograft infiltrating cytotoxic T lymphocytes recognize kidney-specific human minor histocompatibility antigens.
    Poindexter N; Shenoy S; Howard T; Flye MW; Mohanakumar T
    Clin Transplant; 1997 Jun; 11(3):174-7. PubMed ID: 9193838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion.
    Keever-Taylor CA; Bredeson C; Loberiza FR; Casper JT; Lawton C; Rizzo D; Burns WH; Margolis DA; Vesole DH; Horowitz M; Zhang MJ; Juckett M; Drobyski WR
    Biol Blood Marrow Transplant; 2001; 7(11):620-30. PubMed ID: 11760150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A class II-restricted cytotoxic T-cell clone recognizes a human minor histocompatibility antigen with a restricted tissue distribution.
    Holloway PA; Kaldenhoven N; Kok-Schoemaker HM; Dijk Mv; Otten HG; Tilanus M; Postma S; Mutis T; Lokhorst HM; Bloem AC
    Br J Haematol; 2005 Jan; 128(1):73-81. PubMed ID: 15606552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.